Castillo Copper tests stockpile: grades up to 22% copper


Published 02-AUG-2018 12:02 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Castillo Copper Limited’s (ASX:CCZ) has today provided an update on metallurgical test-work carried out on ore from two separate McDonoughs stockpiles along the line of lode.

Two composites formed from bulk samples taken from McDonoughs Portal and Shaft stockpiles along the line of lode have been the focal point of metallurgical test-work in recent months.

Encouragingly, the test-work in the laboratory has demonstrated the ore has beneficiated materially. Furthermore, results to date have confirmed solid copper concentrate recoveries that exceeded 80%, while the grade was up to 22% copper and cobalt 300ppm.

CCZ ore undergoing metallurgical testing

Moving forward, CCZ is optimistic the copper concentrate recovery rates and grades may improve as further metallurgical test-work is conducted. More significantly, these results provide a key insight on copper recoveries and grades for the other historic stockpiles at Cangai Copper Mine yet to be analysed.

CCZ Chairman Peter Meagher commented: “The Board notes the metallurgical test-work done to date on the legacy stockpiles has demonstrated proof of concept. Pleasingly, we have seen solid copper concentrate recoveries and grades, which we expect to continue improving as metallurgical test-work is progressed. Further, we are delighted to have strong interest in our stockpiles from several end user groups.”

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

Legacy stockpiles at Cangai Copper Mine

Monetising legacy stockpiles

CCZ’s geology team has approached the regulator for guidance on how to effectively and efficiently remove the stockpiles from site so the economic benefits can be captured.

The clear options are local third party processing or a direct shipping ore product once regulatory clearance is secured.

CCZ continues to progress discussions with the several prospective off-take partners interested in processing the ore as relevant information comes to hand. Further metallurgical test-work will be undertaken to improve the copper concentrate recovery and grades.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free